Lung Cancer
From the Journals
Lung cancer with ILD patients fare poorly after thoracic radiotherapy
News
FDA approves neoadjuvant nivolumab/chemo for early-stage NSCLC
Nivolumab is the first immune checkpoint inhibitor to be approved for resectable NSCLC.
Latest News
Lung cancer now a growing public health threat
With 2 million new cases in 2020 and nearly 4 million by 2050, experts say air pollution and smoking will continue to drive new lung cancer cases...
Latest News
Should all women be routinely screened for lung cancer?
Study suggests lung cancer screening guidelines should be reassessed to include all women, especially breast cancer survivors.
Latest News
Lung cancer drug price trends cause alarm, highlight need for reform
Prescription oncology drugs may soon be unaffordable for most patients if the trends discovered in the present study continue.
Sponsored Article.
Treatment of Unresectable Stage III Non-small Cell Lung Cancer
Latest News
Older age for menopause raises risk for lung cancer
This is the first study that has shown a causal association between older age of natural menopause and higher risk of postmenopausal lung cancer...
Supplements
NSCLC Management: Advanced by Science, Challenged by Human Barriers
From the Journals
Women at higher risk of serious adverse events from cancer therapy
As cancer treatment becomes increasingly individualized, “sex may be an important consideration.”
Latest News
CMS updates lung screening criteria, more aligned with USPSTF
The expanded Medicare recommendation will address racial disparities associated with lung cancer.
Opinion
ctDNA shows promise for assessing lung cancer treatment response
These are critical therapies because they are given with the intention of improving the chance for cure.